32
Participants
Start Date
May 31, 2002
Primary Completion Date
December 31, 2010
Study Completion Date
January 31, 2012
adjuvant therapy
pegylated interferon alfa
0.3 mg/kg subcutaneously once a week for 4 weeks beginning 2-10 weeks after completion of radiation therapy and continued until disease progression or one of the other off study criteria.
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
National Cancer Institute (NCI)
NIH